Skip to content

Checked

Class IIIDrug recallTerminated

Sirolimus Oral Solution recall

Recalled by Apotex Corp. of Weston, FL · FDA report 05/25/2022

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class III
Low risk
Status
Terminated
Closed 10/05/2023
Recall started
05/03/2022
Distribution
Nationwide

Reason for recall

Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.

Class III: Use of or exposure to the product is not likely to cause adverse health consequences.

Recalled product

Product
Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-6197-2
Lot and code info
Lot: RZ1598, exp. date 02/2023
Quantity
2353 bottles
Recall number
D-0881-2022
Event ID
90114
Initiated by
Voluntary: Firm initiated

Where it was distributed

Nationwide in the USA

  • Nationwide

Recall timeline

  1. 05/03/2022Firm started the recall
  2. 05/18/2022FDA classified it as Class III
  3. 05/25/2022Published in the FDA enforcement report
  4. 10/05/2023FDA closed (terminated) the recall

More recalls from Apotex

Frequently asked questions

Why was Sirolimus Oral Solution recalled?
Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.
What does Class III mean?
Class III is FDA's low risk recall category: use of or exposure to the product is not likely to cause adverse health consequences.
Where was the recalled product sold?
Nationwide in the USA
Is this recall still active?
The FDA lists the recall as terminated (closed 10/05/2023). FDA has determined the recall is complete and closed it.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 05/25/2022 · Do not rely on openFDA to make decisions regarding medical care